Korean J Physiol Pharmacol.
1998 Feb;2(1):119-131.
The inhibitory mechanism of aloe glycoprotein (NY945) on the mediator release in the guinea pig lung mast cell activated with antigen-antibody complexes
- Affiliations
-
- 1Departments of Pharmacology, Yonsei University, College of Medicine, Seoul 120-752, Korea.
- 2Department of Molecular Biology, Korea University, College of Life Science, Seoul 135-075, Korea.
- 3Department of Pharmacology, Seoul National University, College of Medicine, Seoul 110-799, Korea.
- 4Department of Biochemistry, Seoul National University, College of Pharmacy, Seoul 151-742, Korea.
- 5Department of Pharmaceutics, Chunnam University, College of Pharmacy, Chunnam 500-757, Korea.
Abstract
-
It has been reported that the glycoprotein extracted from Aloe has
strong anti-inflammatory response. However, there has been no research
report yet about the effect of Aloe on allergic hypersensitivity
reactivity. By using guinea pig lung mast cells, this study aimed to
examine the effects of Aloe glycoprotein (NY945) on the mediator
releases caused by mast cell activation, and also aimed to assess the
effects of NY945 on the mechanism of mediator releases in the mast cell
activation. We partially purified mast cell from guinea pig lung
tissues by using the enzyme digestion, the rough and the discontinuous
density percoll gradient method. Mast cells were sensitized with IgG,
(anti-OA) and challenged with ovalbumin. Histamine was assayed by
fluorometric analyzer, leukotrienes by radioimmunoassay. The
phospholipase D activity was assessed by the production of labeled
phosphatidylalcohol. The amount of mass 1, 2-diacylglycerol (DAG) was
measured by the (3H)-DAG produced when prelabeled with (3H)myristic
acid. The phospholipid methylation was assessed by measuring the
incorporation of the (3H)methyl moiety into phospholipids of cellular
membranes. Pretreatment of NY945 (10 microgram) significantly decreased
histamine and leukotrienes releases during mast cell activation. The
decrease of histamine release was stronger than that of leukotriene
during mast cell activation. The phospholipase D activity increased by
the mast cell activation was decreased by the dose-dependent manner in
the pretreatment of NY945. The amount of DAG produced by PLC activity
was decreased by NY945 pretreatment. The amount of -mass 1,
2-diacylglycerol produced by activation of mast cells was decreased in
the pretreatment of NY945. NY945 pretreatment strongly inhibited the
incorporation of the (3H)-methyl moiety into phospholipids. The data
suggest that NY945 purified from Aloe inhibits in part an increase of
1, 2-diacylglycerol which is produced by activating mast cells with
antigen-antibody reactions, which is mediated via
phosphatidylcholine-phospholipase D and
phosphatidylinositol-phospholipase C systems, and then followed by the
inhibition of histamine release. Furthermore, NY945 reduces the
production of phosphatidylcholine by inhibiting the methyltransferase I
and II, which decreases the conversion of phosphatidylcholine into
arachidonic acid and inhibits the production of leukotrienes.